Menu
 

Search abstracts


Search results for:

324 match(es)

2007 Beijing (China)

Presentations

September 1

R4 - Forum for innovators in pharmacy practice: Pharmacist advice at the counter - Implementation of Best Practice Standards

September 2

R4 - Forum for innovators in pharmacy practice: Pharmacist advice at the counter - Implementation of Best Practice Standards

September 3

BPP/BPS Joint Symposium (part 1)

G1 - Life long learning and continuing professional development: We have all heard the theory, what is the evidence?

G10 - Financing the healthcare

G17 - Pharmaceuticals and the environment

G18 - How to guarantee the best therapeutic outcome of a pharmaceutical product - The influence of a life cycle

G2 - Experiential learning - Bridging classroom education and pharmacy practice

G25 - Antimicrobial drug resistance - The role of the pharmacy profession in tackling this emerging global health problem

G26 - Risk communication in patient safety: To what extent can pictograms help in labeling?

G33 - Workshop: Nuclear/radiologic pharmacy

G34 - Clinical biology in South East Asia

G9 - FIP/IPSF students’ day: Social dimensions of developing the pharmacy profession

P1 - Personal, cultural and social belief systems and the use of medicines

S1 - Dissolution testing: A pivotal tool for development and quality of drugs

S2 - Pharmacoepidemiology: (a) hepatitis model & (b) antibiotic resistance

Working Group History of Pharmacy

September 4

BPP/BPS Joint Symposium (part 2)

Curbing the tobacco pandemic - The role of the pharmacist

G11 - Trends in community pharmacy – Debating the future of the profession: Forum for policy makers in pharmacy practice

G19 - Clinical trials in Asia

G27 - Customer relationships (part 1)

G28 - Customer relationships (part 2)

G3 - Evidence based practice and complementary medicines: Teaching and learning by example

G35 - Evolution of practices in clinical biology

G36 - Nanotechnology: From science to industrial practice

G4 - Is there enough evidence for the value of pharmacists?

P2 - Regulatory, manufacturing, supply-chain and quality standards issues

S3 - Improving bioavailability/bioequivalence

S4 - Biotechnology

September 5

G13 - Practitioners' Day CPS: Forum I (Part 1)

G14 - Practitioners' Day CPS: Forum I (Part 2)

G21 - Practitioners' Day CPS: Forum II (Part 1)

G22 - Practitioners' Day CPS: Forum II (Part 2)

G23 - WHO/FIP workshop: Herbal medicines: Education and training of pharmacy practitioners

G29 - Medication reviews: From medication counselling towards service delivery

G30 - Good versus bad drug information in the public domain - can you spot the difference?

G37 - Manufacturing and good manufacturing practice IPS (part 1)

G38 - Manufacturing and good manufacturing practice IPS (part 2)

G5 - Short oral presentations FIP Academic Pharmacy Section

G6 - Strengthening the responsible self care of patients

P3 - Technical, scientific and evidence-based information resources about medicines

P4 - Future issues with conventional, and complementary & alternative medicines

S5 - Quality control for natural products

S6 - Research in natural products

September 6

G15 - Continuing education programme: From research to daily practice - Implementing family pharmacy

G24 - Good Manufacturing Practice (GMP) & Good Clinical Practice (GCP)

G31 - The use of informatics to improve medication safety

G32 - Current issues on drug and healthcare information

G39 - Rationalising medication management for emergency response

G7 - The Asian drug market – current topics and challenges

G8 - The challenges of diabetes in Asia

S7 - Impact of individualised medicine in pharmaceutical care

S8 - From knowledge to controlling: Medicinal chemistry based on chemical biology

Poster and Presentations

Academic Pharmacy Section

CPS 1. Innovative ways of collaboration

CPS 3. Counterfeit medicines

CPS 4. The role of the pharmacist in public health

CPS 5. Other

Industrial Pharmacy Section

Pharmacy Information Section

Poster

Academic Pharmacy Section

Administrative Pharmacy Section

Clinical Biology Section

CPS 1. Innovative ways of collaboration

CPS 2. Experiences with patient profiles

CPS 3. Counterfeit medicines

CPS 4. The role of the pharmacist in public health

CPS 5. Other

Hospital Pharmacy Section

Industrial Pharmacy Section

Laboratories and Medicines Control Services Section

Military and Emergency Pharmacy Section

Miscellaneous

Pharmacy Information Section

SIG Bioavailability/Bioequivalence

SIG Biopharmaceutics Classification System

SIG Dissolution/In Vitro Release Performance Testing

SIG Individualised Medicine

SIG Natural Substances

SIG Nuclear/Radiologic Pharmacy

SIG Pharmaceutical Biotechnology

SIG Pharmacoeconomics/Pharmacoepidemiology

Biography

Last update 13 May 2019

FIP Congresses